Dare Bioscience Inc (DARE) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.78 (+4.88%), Market cap $0.03B, 52-week low–high $1.30 ~ $3.27.
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation
Financial statements, price targets, institutional (13F) holdings and related news for Dare Bioscience Inc are updated in real time on BlackAll Trade.
Dare Bioscience Inc trades at $0.78 (+4.88%). Real-time quotes and charts are available on BlackAll Trade.
Dare Bioscience Inc has a market cap of about $0.03B.
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XA